For decades, Warfarin (Coumadin) has been the gold standard drug for atrial fibrillation (Afib) patients to avoid being at a higher risk for stroke and other potentially deadly medical conditions like a pulmonary embolism (PE). While Warfarin is considered relatively safe, it does require patients to have frequent monitoring by…
Xarelto is an anticoagulant medication manufactured by Bayer AG, the German pharmaceutical giant, and Janssen, a subsidiary of Johnson & Johnson, markets it in the United States. Xarelto is one of three relatively new forms of medication marketed to treat patients who suffer from a condition known as atrial fibrillation…
While Bayer AG, the German pharmaceutical giant, has seen a recent increase in quarter-over-quarter profits, sales numbers for their bestselling drug, Xarelto, have actually dropped this past quarter for the first time since the United States Food and Drug Administration (FDA) approved it for market. Xarelto is a member of…
According to a recent news feature from the Madison Record, a woman in Texas is suing Bayer Pharmaceuticals AG, and its United States marketing partner Janssen Pharmaceuticals (Johnson & Johnson) for injuries she alleges was a result of her Xarelto prescription. Xarelto is the brand name for a drug known…
These days it is nearly impossible to watch television without seeing commercials for one of three drugs, which are part of a new group of blood thinning medications known as New Oral Anticoagulants (NOACs). This relatively new class of drugs includes big names like Xarelto, Eliquis, and Pradaxa. Xarelto makers,…
Patients who have a serious health condition known as atrial fibrillation (Afib) are required to take blood-thinning medications to prevent stroke, heart disease, pulmonary embolism (PE) and other serious clotting disorders. Traditionally, this means taking Warfarin. Warfarin is a long existing blood thinning medication now available in generic form. While…
Pradaxa is an oral anticoagulant similar to Xarelto and Eliquis, which has been prescribed to patients with a serious medical condition known as atrial fibrillation (Afib) as an alternative to Warfarin and other traditional blood thinning agents. Afib patients are higher risk for serious clotting disorders that can lead to…
Xarelto, like Eliquis and Pradaxa, is a blood thinner known as a New Oral Anticoagulant (NOAC) or Factor Xa Inhibitor. Patients at risk for heart disease or with clotting disorders are often required to take an anticoagulant to prevent stroke and other serious medical conditions. The traditional therapy used by…
Pradaxa maker, Boehringer Ingelheim, has announced it will be reducing its workforce in New England as well as internationally as it faces defective products lawsuits and declining sales of its blood-thinning medication. Pradaxa is a member of a class of drugs known as New Oral Anticoagulants (NOACs) that is marketed…
One of the main ways drug companies get patients to take their drugs is through direct marketing to potential patients through television, Internet, and magazine advertisements. There was a time when the United States Food and Drug Administration (FDA) did not allow drug companies to direct market to individual users,…